Literature DB >> 12090474

Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis.

Pawel Ciborowski1, Olivera J Finn.   

Abstract

MUC1 is a transmembrane glycoprotein abundantly expressed on the apical surface of human ductal epithelial cells and over entire cell surface of tumors originating from those cells. It is 300 to 500 nm long and has a rigid, rod-like structure protruding from the cell surface. MUC1 expressed by normal cells has heavily O-glycosylated tandem repeat domain while MUC1 on malignant cells is aberrantly O-glycosylated. Substantially reduced (aberrant) glycosylation of the tandem repeat region of tumor MUC1 results in uncovering of the polypeptide core. This new structural feature may play an important role in the attachment of metastasizing tumor cells to tissues at distant sites. We show that MDA-MB-231 cells attaching to the immobilized extracellular matrix proteins (ECM) are higher MUC1 expressers than those non-attaching and that the attachment is inhibited by the addition of non-glycosylated, MUC1 peptide. This 100 a.a. peptide composed of 5 tandem repeats from the tandem repeat domain mimics the forms of MUC1 found in ascites fluid of cancer patients. We also show that this synthetic form of MUC1 inhibited attachment of breast tumor cells to sections of normal human lung tissue and immobilized ECM. We did not find correlation between the expression of Tn (GalNAc-Ser/Thr) epitope and the ability of tumor cells to adhere to the immobilized ECM. These results indicate that the non-glycosylated form of MUC1 plays a role in the initial attachment of carcinoma cells to tissues at distant sites, which may facilitate establishment of metastatic foci.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090474     DOI: 10.1023/a:1015590515957

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  41 in total

1.  Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion.

Authors:  M Yamamoto; A Bharti; Y Li; D Kufe
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

2.  Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas.

Authors:  J Hilkens; J Wesseling; H L Vos; J Storm; B Boer; S W van der Valk; M C Maas
Journal:  Biochem Soc Trans       Date:  1995-11       Impact factor: 5.407

3.  Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.

Authors:  T Yamato; M Sasaki; Y Watanabe; Y Nakanuma
Journal:  J Pathol       Date:  1999-05       Impact factor: 7.996

4.  Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

Authors:  K O Lloyd; J Burchell; V Kudryashov; B W Yin; J Taylor-Papadimitriou
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

5.  Quantitative estimation of serum proteins in newborn and their mothers.

Authors:  S Vishnupriya; T Padma; J S Murty; N Rao; T Seetha
Journal:  Ann Hum Biol       Date:  1984 Sep-Oct       Impact factor: 1.533

6.  The role of mucin in colon-cancer metastasis.

Authors:  B Schwartz; R S Bresalier; Y S Kim
Journal:  Int J Cancer       Date:  1992-08-19       Impact factor: 7.396

Review 7.  Is episialin/MUC1 involved in breast cancer progression?

Authors:  J Hilkens; H L Vos; J Wesseling; M Boer; J Storm; S van der Valk; J Calafat; C Patriarca
Journal:  Cancer Lett       Date:  1995-03-23       Impact factor: 8.679

Review 8.  Osteolytic bone metastasis in breast cancer.

Authors:  T Yoneda; A Sasaki; G R Mundy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Metastasis from human breast cancer cell lines.

Authors:  J E Price
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Authors:  J Wesseling; S W van der Valk; H L Vos; A Sonnenberg; J Hilkens
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  25 in total

1.  Galectin-1 binds mucin in human trophoblast.

Authors:  Zanka Bojić-Trbojević; Milica Jovanović Krivokuća; Nikola Kolundžić; Miloš Petronijević; Svetlana Vrzić-Petronijević; Snežana Golubović; Ljiljana Vićovac
Journal:  Histochem Cell Biol       Date:  2014-05-23       Impact factor: 4.304

2.  The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours.

Authors:  H Yang; N-H Cho; S-Y Seong
Journal:  Clin Exp Immunol       Date:  2009-07-17       Impact factor: 4.330

3.  A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.

Authors:  Praveen Agrawal; Barbara Fontanals-Cirera; Elena Sokolova; Samson Jacob; Christopher A Vaiana; Diana Argibay; Veronica Davalos; Meagan McDermott; Shruti Nayak; Farbod Darvishian; Mireia Castillo; Beatrix Ueberheide; Iman Osman; David Fenyö; Lara K Mahal; Eva Hernando
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

4.  Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.

Authors:  Małgorzata Borzym-Kluczyk; Iwona Radziejewska; Marzanna Cechowska-Pasko
Journal:  Clin Exp Nephrol       Date:  2014-08-05       Impact factor: 2.801

Review 5.  Glycobiology of the ocular surface: mucins and lectins.

Authors:  Pablo Argüeso
Journal:  Jpn J Ophthalmol       Date:  2013-01-17       Impact factor: 2.447

6.  Antiadhesive character of mucin O-glycans at the apical surface of corneal epithelial cells.

Authors:  Mika Sumiyoshi; Jessica Ricciuto; Ann Tisdale; Ilene K Gipson; Flavio Mantelli; Pablo Argüeso
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

Review 7.  Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours.

Authors:  María José Serrano Fernádez; Juan Carlos Alvarez Merino; Iñigo Martínez Zubiaurre; Ana Fernández García; Pedro Sánchez Rovira; José Antonio Lorente Acosta
Journal:  Clin Transl Oncol       Date:  2009-10       Impact factor: 3.405

8.  Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.

Authors:  Rahat Jahan; Muzafar A Macha; Satyanarayana Rachagani; Srustidhar Das; Lynette M Smith; Sukhwinder Kaur; Surinder K Batra
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-16       Impact factor: 5.187

Review 9.  Glycosylation Changes in Brain Cancer.

Authors:  Lucas Veillon; Christina Fakih; Hadi Abou-El-Hassan; Firas Kobeissy; Yehia Mechref
Journal:  ACS Chem Neurosci       Date:  2017-11-07       Impact factor: 4.418

Review 10.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.